Hone Bio

Private

BristolHealthcare & Life Scienceshttps://hone.bio/

Last Round

Series A

Mar 16, 2021

Total Funding Raised

$6.5M

Company Overview

Hone Bio is a biotechnology company developing a lipid nanoparticle (LNP) targeting technology for enhanced drug delivery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Advanced Materials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

LNP targetingtargeted drug deliverydrug delivery platformliver detargetingextrahapatic deliveryLNP deliveryprotein engineeringnon-viral deliveryfusion proteingene therapy deliverymRNA deliverylipid nanoparticleplatform licensingcancer immunotherapyCAR-T therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hone Bio Comps

Public and private peers based on sector, stage, and business model.

Hone Bio comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Hone Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Mar 16, 2021
Seed	Nov 25, 2019

View all Funding Rounds

Hone Bio Investors

Notable investors and investment history

Hone Bio investors
Investor	Rounds
Future Planet Capital Regional	Series A, Seed
Bristol Private Equity Club	Series A, Seed
Meltwind Advisory	Series A
University of Bristol Enterprise Fund	Series A, Seed
Science Creates Ventures	Series A
Luminous Ventures	Series A
Outsized Ventures	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 16, 2021
$5M round led by Science Creates Ventures.
Nov 25, 2019
$1.5M raised from Parkwalk Advisors and others.

View all signals

Hone Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Hone Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hone Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersBristol

Employee Range-

Year Founded2017

Last FundingMar 16, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.